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ABSTRACT
The proper dissection of the molecular mechanisms governing the
specification and differentiation of specific cell types requires isolation
of pure cell populations from heterogeneous tissues and whole
organisms. Here, we describe a method for purification of nuclei from
defined cell or tissue types in vertebrate embryos using INTACT
(isolation of nuclei tagged in specific cell types). This method,
previously developed in plants, flies and worms, utilizes in vivo
tagging of the nuclear envelope with biotin and the subsequent
affinity purification of the labeled nuclei. In this study we successfully
purified nuclei of cardiac and skeletal muscle from Xenopus using this
strategy. We went on to demonstrate the utility of this approach by
coupling the INTACT approach with liquid chromatography-tandem
mass spectrometry (LC-MS/MS) proteomic methodologies to profile
proteins expressed in the nuclei of developing hearts. From these
studies we have identified the Xenopus orthologs of 12 human
proteins encoded by genes, which when mutated in human lead to
congenital heart disease. Thus, by combining these technologies we
are able to identify tissue-specific proteins that are expressed and
required for normal vertebrate organ development.
KEY WORDS: INTACT, Xenopus, Cardiac muscle, Proteomics,
Skeletal muscle
INTRODUCTION
The study of organs and tissues is often confounded by the inability
to isolate relatively pure populations of a defined cell type or cell
lineage. These experimental limitations reduce the potential of
emerging highly sensitive technologies, such as high-throughput
sequencing and proteomics. Such technologies are sensitive to
contaminating cells or tissue types, which can lead to an escalated
noise-to-signal ratio. A number of methods to circumvent these
problems have been developed. For example, laser microdissection
of cells can be used to isolate relatively pure populations of cells
from heterogeneous embryonic or adult tissue types for RNA
transcript and proteomics profiling (Agostini et al., 2011; Bonnet et
al., 2011; Erickson et al., 2009; Golubeva et al., 2013; Imamichi et
al., 2001; Longobardi et al., 2012; Rabien, 2010; Shapiro et al.,
2012; Strasser et al., 2010; Zivraj et al., 2010). Alternatively, pure
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cell populations can be isolated on the basis of the expression of a
tissue- or cell-specific surface antigen using, for example, panning
or fluorescence-activated cell sorting (FACS) (Barker et al., 1975;
Barres et al., 1988; Mage et al., 1977; Wysocki and Sato, 1978,
Dorrell et al., 2008; Flores-Langarica et al., 2005; Hoi et al., 2010;
Lawson et al., 2007; Osorio et al., 2008; Pruszak et al., 2009;
Sugiyama et al., 2007; Shen et al., 2003, Claycomb et al., 1998).
However, these approaches require either that the cell population of
interest expresses a unique surface antigen or a reporter construct(s)
that is exclusive to a specific cell or tissue type (Aubert et al., 2003;
Bonn et al., 2012a; Bonn et al., 2012b; Fox et al., 2005; Jesty et al.,
2012; Pruszak et al., 2007; Von Stetina et al., 2007). A major
shortcoming to these types of approaches is availability of antibodies
against cell surface receptors and/or promoters with high fidelity to
the cell type(s) of interest.
Current methodologies have made possible a surrogate approach
through the induction and differentiation of multipotent or totipotent
cells, i.e. embryonic stem cells (ESCs) or induced pluripotent stem
cells (iPSCs) (Ahmed et al., 2011; Caiazzo et al., 2011; Kim et al.,
2009; Kim et al., 2008; Kubo et al., 2004; Laflamme et al., 2007;
Laflamme et al., 2005; Lamba et al., 2006; Lee et al., 2000;
Maekawa et al., 2011; Okita et al., 2007; Pang et al., 2011; Park et
al., 2008; Qian et al., 2012; Szabo et al., 2010; Wernig et al., 2007;
Zhou et al., 2008). The in vitro differentiation of ESCs or iPSCs
offers the additional advantage that precursor or intermediary cell
states can be isolated and assessed (Chen et al., 2013; Paige et al.,
2012; Wamstad et al., 2012). However, these methods are
compromised in that the induced differentiated cells are most often
not a pure population, nor are they often entirely reflective of an
endogenous cell type (e.g. Croft and Przyborski, 2006; Pan et al.,
2009).
To bypass these technical issues an alternative approach has been
pioneered in Arabidopsis thaliana whereby pure populations of
nuclei can be isolated from a defined cell or tissue type using nuclei
tagged in specific cell types (INTACT) (Deal and Henikoff, 2010).
This technology is based on a binary transgene-mediated approach
to specifically label and tag nuclei of a specific cell type(s). When
the two transgenes are co-expressed nuclei can be labeled in a
spatial and temporal manner. The methodology has been combined
with a variety of approaches including RNA, protein and chromatin
profiling assays in plants and invertebrates (Deal and Henikoff,
2010; Deal and Henikoff, 2011; Henry et al., 2012; Steiner et al.,
2012). However to date, the INTACT method has not been applied
to a vertebrate model system.
Here, we describe the application of the INTACT method in the
study of the frog, Xenopus, an established model for vertebrate
development. We report that nuclei derived from Xenopus heart and
skeletal muscle can be labeled and affinity purified using the
INTACT method. We further demonstrate the utility of coupling
INTACT with a mass spectrometry-based proteomics approach to
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profile proteins expressed in the nuclei of developing Xenopus
hearts. Our optimized bioinformatics workflow identified 502
protein clusters with high confidence, 12 of which represent the
Xenopus orthologs of human proteins encoded by genes that when
mutated lead to congenital heart disease (CHD). Collectively, these
studies present a set of general technologies for the effective
enrichment of proteins in a cell- or tissue-specific manner in
vertebrates.
RESULTS
Expression of INTACT components in Xenopus embryos
The Xenopus model system has historically been used to study a
wide array of developmental processes and has the benefit of
producing vast quantities of relatively large, externally developing
eggs. Crucially, many of the processes and genes involved in
development are highly conserved between Xenopus and human and
have been characterized in detail (Angelo et al., 2000; Bartlett et al.,
2007; Bartlett and Weeks, 2008; Brown et al., 2003; Burdine and
Schier, 2000; Gormley and Nascone-Yoder, 2003; Heimeier et al.,
2010; Hellsten et al., 2010; Hirsch and Harris, 1997; Horb and
Thomsen, 1999; Jiang and Evans, 1996; Kaltenbrun et al., 2011;
Mohun et al., 1987; Pearl et al., 2009; Showell et al., 2006;
Steelman et al., 1997; Wallingford, 2006; Zon et al., 1991). Xenopus
has the additional advantages that embryos can be manipulated by
overexpression through microinjection of mRNA or transgenesis,
protein depletion with morpholino oligonucleotides, and targeted
mutagenesis by zinc finger nucleases and transcription activator-like
effector nucleases (TALENs) (Amaya et al., 1991; Hopwood and
Gurdon, 1990; Lei et al., 2012; Nakajima et al., 2012; Sakuma et al.,
2013; Tandon et al., 2012; Young et al., 2011). Recent annotation of
the X. tropicalis genome (Hellsten et al., 2010), a draft sequence of
the X. laevis genome, and the advent of new transgenic lines has
reinforced this model as ideal for studying vertebrate development.
The INTACT system is a binary trangenic system. The first
transgene, referred to as the nuclear targeting fusion construct (NTF)
consists of three parts: (1) a nuclear envelope protein to target the
NTF to the nuclear membrane; (2) an enhanced green fluorescent
protein (eGFP) cassette to visualize the NTF; and (3) a biotin ligase
receptor protein (BLRP) that provides a substrate for the addition of
biotin. Crucial to this methodology is the BLRP, a peptide with a
sequence that has not been identified in any invertebrate or
vertebrate genome, and therefore, labeling of BLRP is highly
specific. Moreover, exposure of the BLRP-tagged protein to the
BirA enzyme, introduced through a second transgene, results in
quick (45 seconds or less) stable conjugation of biotin to the protein
of interest (Beckett et al., 1999; Wong et al., 1999). The tagged
protein can in turn be identified or isolated by streptavidin (Maine
et al., 2010; Roesli et al., 2006; van Werven and Timmers, 2006;
Wang et al., 2006).
Previous studies have utilized a species-specific nuclear envelope
protein in plants, flies and worms (Deal and Henikoff, 2010; Deal
and Henikoff, 2011; Steiner et al., 2012). In this regard, we cloned
the nuclear envelope protein nucleoporin (Nup35) from Xenopus
and fused it in frame with an eGFP::BLRP cassette to generate the
Xenopus nuclear targeting construct, xNTF (Fig. 1A). To visualize
the second transgene, which biotinylates xNTF in vivo, we tagged
BirA with mCherry (Fig. 1B) (Schäffer et al., 2010).
Introduction of xNTF or BirA::mCherry mRNA into Xenopus
embryos led to robust expression of eGFP and mCherry,
respectively, throughout the embryos, beginning at the mid-blastula
transition, with expression persisting until at least late tadpole stages
(stage 43; Fig. 1A-C, data not shown). Western blot analysis
confirmed expression of xNTF and BirA proteins of the predicted
size, and crucially, injected embryos displayed no overt phenotype
throughout development (Fig. 1D). Taken together, these data
demonstrate that xNTF and BirA::mCherry can be expressed in
Xenopus embryos and that their expression is not deleterious to early
development.
Affinity isolation of NTF using streptavidin
Having established the expression of xNTF and BirA::mCherry in
Xenopus, we sought to confirm that the xNTF transgene can be
biotinylated with endogenous biotin. To this end, xNTF mRNA was
injected into Xenopus embryos in the presence or absence of
Fig. 1. Affinity isolation of biotin-tagged
proteins from Xenopus embryos.
(A-C) Schematic of Nup35::eGFP::BLRP(xNTF)
and BirA::mCherry fusion proteins, and
corresponding images of a Xenopus embryo co-
injected at the one-cell stage with capped mRNA
coding for each fusion. Lateral view of a stage 23
embryo with anterior to the left and dorsal up.
(D) Western blot analysis of embryos injected
individually and together with xNTF and
BirA::mCherry shows that the proteins are of the
correct size. xNTF was detected with anti-GFP
antibodies, and BirA was detected by anti-BirA
antibodies. (E) Immunoprecipitation of xNTF with
streptavidin-conjugated beads, followed by
western blot analysis shows that xNTF is efficiently
isolated from embryos by probing with anti-GFP or
streptavidin-HRP. *A potential translation product
of BirA::mCherry corresponding to the size of BirA
protein alone. **Endogenously biotinylated
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BirA::mCherry mRNA. Lysates were collected at mid-neurula (stage
23) and biotinylated proteins were affinity purified with streptavidin-
coated Dynabeads (Invitrogen). Western blot analysis of the
resulting pull-downs with an anti-GFP antibody showed a highly
efficient and specific isolation of xNTF from embryos co-injected
with xNTF and BirA::mCherry, but not in samples derived from
embryos injected with xNTF alone (Fig. 1E). In vivo labeling of
xNTF was further verified by probing western blots with
streptavidin-HRP (Fig. 1E). Collectively, these results demonstrate
that xNTF can be efficiently biotinylated in vivo using endogenous
biotin, and further show the xNTF construct can be isolated in a
highly specific manner from Xenopus embryos.
Cell type-specific expression of xNTF
We next recovered nuclei from Xenopus embryos that expressed
xNTF and BirA::mCherry or xNTF alone by streptavidin affinity
purification. We found that intact nuclei were successfully obtained
from embryos expressing xNTF and BirA::mCherry (Fig. 2E-H),
whereas we were unable to isolate any nuclei from embryos
expressing xNTF alone (Fig. 2A-D). Thus, the binary transgenic
system of xNTF and BirA::mCherry can be used to label and
recover intact nuclei in vertebrates.
To test the tissue specificity of the INTACT system in Xenopus,
the xNTF transgene was expressed in a restricted fashion
(Fig. 3A,B) using the mlc2p regulatory element, and independently,
the cardiac actin regulatory element. mlc2p is expressed in
cardiomyocytes from mid-neurula (stage 26) onwards (Latinkić et
al., 2004) and the cardiac actin (CA) element, is co-expressed with
mlc2p in the cardiomyocytes but in addition is expressed in the
developing somitic tissue (Latinkić et al., 2002). In parallel, we
generated a transgene that uniformly expresses BirA under control
of the CMV promoter.
All transgenes were introduced into Xenopus using restriction
enzyme-mediated integration (REMI) (Amaya and Kroll, 1999;
Kroll and Amaya, 1996; Mandel et al., 2010). Resulting live
embryos were demonstrated to express xNTF in the respective
tissue-specific manner (three independent experiments, 40-60% of
embryos expressing, n>100 embryos per experiment; Fig. 3C-F). As
previously observed for the REMI method in Xenopus (Small and
Krieg, 2003), the majority of eggs injected with both xNTF and
BirA transgenes co-expressed the two constructs. Integration of the
transgenes was verified by genomic PCR of tailclips (Showell and
Conlon, 2009) from xNTF, GFP-positive stage 40 embryos (85%
co-integration from n=20 animals) and integration of the transgene
was further substantiated in juvenile frogs by genomic PCR of
toeclips (supplementary material Fig. S1). As predicted, xNTF was
localized to the nuclear periphery (visualized by eGFP) in all
positive trangenic embryos (Fig. 4A-C).
To establish that the xNTF transgenes were successfully
biotinylated in vivo, we analyzed xNTF in CA::xNTF, CMV::BirA
tadpoles by streptavidin staining. Consistent with the expression of
CA::reporter constructs, we observed expression of biotinylated
Fig. 2. Affinity isolation of xNTF-tagged
nuclei. Streptavidin-coated magnetic beads
incubated with nuclei from embryos injected
with mRNA encoding xNTF with or without
BirA::mCherry. (A-D) Fluorescent DAPI (A),
xNTF (eGFP; B), BirA::mCherry (Texas Red;
C) and phase-contrast (D) images of magnetic
beads after nuclear purification of xNTF in the
absence of BirA. Autofluorescing beads are
detectable throughout the field, but no nuclei.
(E-H) Fluorescent DAPI (E), eGFP (F), Texas
Red (G) and phase-contrast (H) images of
magnetic beads after nuclear purification of
xNTF. Note the presence of eGFP and
BirA::mCherry-positive nucleus (arrow) and
presence of magnetic beads coating nucleus
(arrowheads). Scale bars: 50 μm.
Fig. 3. Generation of transgenic embryos expressing xNTF. (A,B) Schematics of constructs used to generate transgenic embryos expressing xNTF in the
striated muscle and myocardium (A) and the myocardium only (B). (C-F) Representative images of stage 38 (C,E) and stage 40 (D,F) embryos harboring the
respective transgenes. Embryos express xNTF (eGFP) in the expected pattern (C,D), and appear morphologically normal (E,F). eGFP in myocardium is fainter
than staining in somites and masked by autofluorescence of the gut in C. Images shown are lateral views with anterior to the left and dorsal up. BF, bright field;
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xNTF in the myocardium and somites (Fig. 4D-I). Importantly, we
did not detect eGFP expression or the presence of biotin in other cell
types (Fig. 4D-F). We did not observe xNTF by anti-GFP
immunostaining in non-muscle tissue of mlc2p::xNTF; CMV::BirA
or CA::xNTF; CMV::BirA embryos, strongly implying that the
CMV promoter for the BirA transgene does not interfere with
expression of the other two transgenes. Because we did not observe
any overt phenotypes or cardiac abnormalities (supplementary
material Movie 1), expression of the biotinylated xNTF proteins did
not appear to have any adverse effects on muscle or heart
development.
Enrichment of muscle-specific nuclei
To confirm that the INTACT method can successfully be used in
vertebrates to isolate nuclei in a tissue-specific manner, we
examined the expression levels of cardiac- and skeletal muscle-
specific genes in nuclei derived from CA::xNTF, CMV::BirA
embryos at mid-tadpole stage (stage 40). Indeed, we found a
significant enrichment in the expression of the muscle-associated
genes acta1, myh6, actc1, tpm2, myoD, mef2a and nkx2-5 isolated
from CA::xNTF, CMV::BirA versus non-bead-bound nuclei
(Fig. 5A,B). Consistent with the observation that many of these
genes are also expressed in non-muscle and non-cardiac tissues
(Amin et al., 2013; Tandon et al., 2013; Fu et al., 1998; Hopwood
and Gurdon, 1990; Wong et al., 1994; Newman and Krieg, 1998;
della Gaspera et al., 2009; Martin and Harland, 2001), we also
observe expression of these genes in the non-bound fraction, albeit
at significantly lower levels.
To further validate enrichment of cardiomyocyte and skeletal
muscle nuclei, we examined genes not normally detected in muscle
or heart including eomes, foxa2, pteg, rgn, rasip1 and ncam1 (Balak
et al., 1987; Lee et al., 2010; Misawa and Yamaguchi, 2000; Ryan
et al., 1998; Xu et al., 2009; Zorn and Mason, 2001). Crucially, we
found a significant reduction in expression of all of these genes in
bead-bound nuclei, confirming that the CA::xNTF, CMV::BirA-
isolated nuclei are enriched for cardiac and skeletal muscle
transcripts (Fig. 5C). Taken together, these results show that the
INTACT method successfully enriches for cell-type-specific nuclei
of the vertebrate organism Xenopus.
Proteomic profiling of enriched cardiac nuclei
Previous studies have demonstrated the ability to use INTACT-
derived nuclei for transcriptional and chromatin profiling (Deal and
Henikoff, 2010; Deal and Henikoff, 2011; Steiner et al., 2012). We
next set out to test the utility of coupling INTACT with proteomic
profiling. Given Xenopus proteomes have not achieved full manual
annotation and curation, we used both SwissProt and TrEMBL
Xenopus protein sequence databases containing Xenopus laevis and
Xenopus tropicalis data. This combination greatly benefits
computational peptide-to-spectral assignments by allowing for
higher proteome coverage. However, one drawback is the likelihood
of obtaining redundant and/or non-unique protein hits. To minimize
this effect while retaining relationships between related proteins, we
employed both protein grouping and protein clustering, which
assembles protein groups based on their shared peptide evidence
(see Materials and Methods). From three biological replicates of
stage 46 mlc2p::xNTF; CMV::BirAmCherry transgenic embryos,
502 protein clusters containing 909 annotated protein sequences
(supplementary material Table S2) were consistently detected in the
three replicates with a minimum of two unique peptides (Fig. 6A).
Moreover, ten biological process terms were significantly over-
represented compared with the total Ensembl Xenopus tropicalis
genome, representing predominantly nuclear-related biological
functions (Fig. 6B). Specifically, one of the largest molecular
function gene ontology terms contained 178 proteins annotated as
nucleic acid-binding proteins (supplementary material Table S3),
which showed similar detection across biological replicates
compared with all proteins (compare Fig. 6C and 6B).
Fig. 4. Demonstration of xNTF localization and biotin
tagging in transgenic animals. (A-C) xNTF localization in
the somites as detected by eGFP (A); nuclei were marked
with DAPI (B) and the merged image is shown in C. Images
are from whole embryos with anterior to the left and dorsal up. 
(D-F) Transverse sections through the heart (dorsal is up)
show expression of xNTF (D) in the myocardium (m) but not
the endocardium (e), and corresponding localization of
biotinylated xNTF as detected by streptavidin (E). Images
were overlaid with DAPI to show the nuclei in F. (G-
I) Magnified image of the boxed region in D-F. Scale bars: 200
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Advancements in proteomic profiling methods also permits
simultaneous measurement of abundances in large-scale experiments,
often by stable isotope-labeled or ‘label-free’ methods (Baker et al.,
2010; Dong et al., 2007; Joshi et al., 2013). To demonstrate the
feasibility of quantitative proteomics strategies within enriched cardiac
nuclei, we evaluated the peptide-level reproducibility (percentage
coefficient of variation; % CV) between biological replicates. Because
stable isotope labeling has not yet been demonstrated in Xenopus, we
chose a label-free approach as a measure of relative abundance, which
can be easily incorporated into existing proteomic workflows. Using
weighted spectral counts, the % CV was calculated for each protein
cluster with at least three spectral counts detected in all three
replicates. For the nucleic acid-binding proteins, more than 94% of
proteins had less than 50% spectral count variation (Fig. 6D, orange
bars), which was similar to the spectral count variation of total
proteins (Fig. 6D, blue bars). These results are consistent with the
existing spectral count literature that has shown the 95% confidence
range of replicate measurements is often within a relative protein
abundance of less than twofold (Old et al., 2005).
Further data mining of the filtered protein set demonstrated that
at this single stage of cardiac development we were able to identify
the Xenopus orthologs of 12 human nuclear proteins encoded by
genes that when mutated in human are associated with congenital
heart disease (CHD; Table 1). Thus, using these technologies, we
are able to isolate and profile proteins that are expressed in, and
required for, normal cardiac development.
DISCUSSION
Here, we report the development and application of the INTACT
method in Xenopus. We have gone on to demonstrate the feasibility
of combining the INTACT methodologies with a liquid
chromatography-tandem mass spectrometry (LC-MS/MS)
proteomic approach to profile proteins expressed in the nuclei of
developing hearts. As part of these studies we generated a vertebrate
NTF transgene by cloning the nuclear pore protein nup35 from
Xenopus in frame with the GFP-BLRP cassette used previously to
visualize and isolate tag nuclei (Deal and Henikoff, 2010; Deal and
Henikoff, 2011; Steiner et al., 2012). Nup35 encodes a nucleoporin
protein that is highly conserved (71%/84% identical/similar to
mouse and 72%/85% to human) and has a crucial role in nuclear
envelope formation and function in vertebrates (Hawryluk-Gara et
al., 2008). Nup35 attaches to the nuclear lamina through its
interaction with lamin B and offers the advantage that it is relatively
small and its function and cellular localization are unaffected by
Fig. 5. INTACT purified nuclei are enriched for cardiac and/or skeletal muscle markers. (A,B) qRT-PCR results show that skeletal muscle structural genes
(A) and cardiac or skeletal transcription factors (B) are enriched in bead-bound nuclei compared with flow-through of total nuclei. All expression levels are
relative to eef1a and flow-through was normalized to one. Expression of gapdh, another housekeeping gene, was unchanged in bead-bound nuclei compared
with flow-through nuclei. (C) qRT-PCR demonstrates that INTACT nuclei show reduced levels of gene expression of non-muscle genes. Error bars represent
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fusion to enhanced green fluorescent protein (eGFP) (Hawryluk-
Gara et al., 2005). Thus, the vertebrate version of NTF that we have
generated from Xenopus is most likely to be capable of functioning
similarly in other vertebrate model systems. Thus these methods,
protocols, reagents and workflow should be generally applicable to
a wide range of vertebrate model systems and tissue types.
Cardiac profiling
CHD occurs in an estimated 1% of live births and an estimated 5%
of stillbirths are attributed to human CHD, making it one of the most
common diseases among children (Hoffman, 1995; Hoffman and
Kaplan, 2002). Moreover, prognosis and outcomes have stagnated
over the last few decades and remain exceptionally poor (Bruneau,
2013; Chin et al., 2012). To gain a better understanding of heart
development and disease, it has become essential to gain a basic
knowledge of proteins that are expressed in the embryonic and the
adult heart. To this end, recent advances in proteomic profiling have
been applied to cardiac tissue but, to date, have mainly focused on
the adult heart and the generation of biomarkers associated with
specific cardiac abnormalities (Buscemi et al., 2005; Chen et al.,
2008; Cieniewski-Bernard et al., 2008; Gramolini et al., 2008; Kim
et al., 2006; Koomen et al., 2006; Peronnet et al., 2006; Weekes et
al., 1999; Wei et al., 2009).
Xenopus has historically been used to study a wide array of
developmental processes and is particularly amenable to examining
the cardiac system because, together with the benefit of producing
vast quantities of relatively large externally developing eggs, many
of the developmental processes and genes involved in cardiac
specification, differentiation and growth are conserved between
Xenopus and human and have been characterized in detail (reviewed
by Kaltenbrun et al., 2011; Mohun et al., 2003; Warkman and Krieg,
2007). Furthermore, compared with other higher vertebrate models,
Xenopus embryos can survive for longer without a properly
functioning heart or circulatory system, enabling the observation of
later consequences of cardiac malfunction. Moreover, the Xenopus
model allows for tissue explantation for study in isolation (Afouda
and Hoppler, 2009; Langdon et al., 2007; Raffin et al., 2000), as well
as microinjection of overexpression constructs and antisense
morpholino oligonucleotides to manipulate gene function (Brown et
al., 2007; Brown et al., 2005; Christine and Conlon, 2008; Sive et
al., 2000; Tada et al., 1997; Tandon et al., 2012). Crucially, studies
have demonstrated a direct correlation between depleting cardiac
Table 1. Proteins identified from INTACT-derived cardiac nuclei associated with congenital heart disease
Protein Associated human CHD References
Cct4 Hypertrophic and dilated cardiomyopathies (CMs) (Vang et al., 2005)
Hist1h Conotruncal defects (Zaidi et al., 2013)
Lmna Dilated CM, atrioventricular (AV) conduction defect (Al-Saaidi et al., 2013; Ostlund et al., 2001)
Lmnb1 Dilated CM, AV conduction defect (Al-Saaidi et al., 2013; Ostlund et al., 2001)
Lmnb2 Dilated CM, AV conduction defect (Al-Saaidi et al., 2013; Ostlund et al., 2001)
Lmnb3 Dilated CM, AV conduction defect (Al-Saaidi et al., 2013; Ostlund et al., 2001)
Mak16 Conotruncal defects (Zaidi et al., 2013)
Nop2 Conotruncal defects (Zaidi et al., 2013)
Pes1 Conotruncal defects (Zaidi et al., 2013)
Prpf4 Conotruncal defects (Zaidi et al., 2013)
Wdr5 Tetralogy of Fallot, right aortic arch, aberrant LSA, coronary abnormality (Zaidi et al., 2013)
Znf326 Conotruncal defects (Zaidi et al., 2013)
Fig. 6. Proteomic profiling of INTACT-
enriched Xenopus cardiomyocyte
nuclei. (A) Venn diagram comparison of
the total proteins identified in three
biological replicates (n=781).
(B) g:profiler biological process gene
ontology enrichment analysis. Only
terms that were significant versus the
annotated Xenopus tropicalis genome
are shown (–log(P-value) >2). (C) Venn
diagram comparison of proteins
identified with ‘nucleic acid binding’
molecular function gene ontology
(n=178). (D) Distribution of weighted
spectral count percentage coefficient of
variation (% CV, n=3). % CV was
calculated for shared proteins identified
in A and C, corresponding to total
proteins (blue bars) and nucleic acid-
binding proteins (orange bars) with at
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proteins in Xenopus to that of genetic mutations in mouse or in
human CHD patients (Kaltenbrun et al., 2011).
In this study, we examined a compendium of cardiac proteins
from late tadpole stage Xenopus (stage 46), a stage equivalent to
E12.5 in mouse and day 40 (Carnegie stage 10) in human. Our
results identified 502 protein clusters from purified cardiomyocyte
nuclei. We note that this number of proteins is less than reported for
cardiac protein profiling in the adult fly or mouse heart (Bousette et
al., 2009; Cammarato et al., 2011). However, there are several
possible reasons for this discrepancy. First, these studies were
conducted with whole heart tissue that examined expression in all
cellular compartments. By contrast, our study was conducted
exclusively on the nuclear fraction and restricted solely to the
cardiomyocyte cell population, which constitutes a minority of the
total cardiac cell number. Second, the current incompleteness in the
sequence and gene ontology annotation of the X. laevis and X.
tropicalis proteomes and genomes may limit overall coverage. And
third, the reported 502 protein identifications reflect the number of
protein clusters, which represent as an upper limit of 909 potential
protein products annotated within the X. laevis and X. tropicalis
UniProt databases (supplementary material Table S2). In other
words, the number of gene products at the cluster level is an
underestimate of the true number, as protein clustering can group
related but genetically distinct entries. For example, we identified a
five member cluster of Ybx1 (Y-box-binding) proteins, which
contains the distinct genes ybx1, ybx2-a, ybx2-b, and nsep1 and
ybx3. Because this hierarchical relationship is retained, this provides
an advantage for comparative proteomic studies, as individual
cluster members, from the subset of functionally over-represented
or quantitatively regulated protein clusters, can be subjected to a
second round of interrogation to reveal isoform-specific regulation.
An equally important aspect of protein clustering is the ability to
address sequence database redundancy. Although inclusion of
manually and automatically annotated protein sequences in the
analysis increased the identification of non-shared peptide
sequences, this does not necessarily mean the individual cluster
members are ‘unique’ gene products. Identifications of this type
often have a high rate of sequence identity and could correspond to
laevis and tropicalis paralogs or protein fragment database entries
within the same species. For these reasons, our bioinformatics
analysis was performed on the conservative estimate of the total
number of protein clusters identified.
Additionally, the ability to perform data redundancy reduction
has the advantage of permitting rapid identification of previously
unidentified or uncharacterized protein products that were not
assigned to a protein cluster. For example, of the 502 proteins, four
protein accessions have not been mapped to Xenopus genes, 17
have been mapped, but to genes of uncertain functions (LOC
symbols), and seven were annotated with Mammalian Gene
Collection (MGC) symbols. Potential gene products that have only
been predicted at the transcript level represent high-value
candidates that merit more careful study. Overall, these aspects of
protein clustering analysis demonstrate several distinct advantages
when performing ‘-omic’ studies with organisms that are not
completely annotated.
Cardiac profiling and CHD
Recently, a comprehensive study using high throughout sequencing
to identify the incidence of de novo mutations in adult heart tissue
from CHD patients found a strong association between CHD and
mutations in chromatin-modifying proteins (Zaidi et al., 2013). In
our present study we identified the Xenopus ortholog of seven of
these proteins in all replicates of cardiac nuclei. Data mining of our
samples revealed another five proteins with a known association
with CHD. Collectively, these findings emphasize the utility of
coupling an INTACT-based approach with LC-MS/MS to identify
and characterize those proteins expressed during embryonic
development, and further emphasize the utility of using Xenopus to
model human heart development (Kaltenbrun et al., 2011). We
envisage that changes in absolute levels of these CHD-associated
proteins can be studied at different stages of development using
targeted mass spectrometry approaches. Our results form an
important baseline for such future studies, providing information
necessary for selecting signature peptides for targeted quantification
by methods such as selected reaction monitoring (Picotti et al.,
2010). The use of Xenopus as a model system is further emphasized
by the observation that most proteomic profiling studies of
embryonic and adult tissue are compromised by the availability of
endogenous tissue. Given that Xenopus can provide a virtual
limitless supply of tissue, and given the INTACT method is not
restricted by sample size, we anticipate that as the annotations of
Xenopus near completion, coupling the INTACT method with
protein profiling will in the future produce a compendium of
proteins in Xenopus that will at the least equal that of studies in fly,
mouse or other model systems.
MATERIALS AND METHODS
Generation of INTACT plasmids for Xenopus transgenics and
capped mRNA production
Full-length nup35 was cloned from X. laevis cDNA (stage 40 embryos) by
PCR; primers: 5¢-gcgcccgggATGATGGCTGCTGCTTTCTC-3¢ and 5¢-
cgcgctagcCCAGCCAAACATATACTCCA-3¢ with engineered XmaI and
NheI sites, respectively. Nup35 PCR product was cloned in frame with
pADF8p-eGFP-BLRP (kindly provided by Roger Deal and Steven Henikoff,
Fred Hutchinson Cancer Center, Seattle, WA, USA), removing the pADF8p
promoter to generate the plasmid UNC208 (Nup35::eGFP::BLRP).
BirA::mCherry was cloned from pBY2982 (Addgene) using XhoI and NotI,
then cloned into pSP64TxB (Krieg and Melton, 1984) to generate plasmid
UNC328. UNC208 and UNC328 were linearized with XhoI or XbaI,
respectively, and used to generate capped mRNA with mMESSAGE
mMACHINE T3 and SP6 Kits (Ambion), respectively.
NTF was cloned downstream of the tissue-specific promoters mlc2p
(Latinkić et al., 2004) and cardiac_actin_p (Latinkić et al., 2002) by
amplification from UNC208 with 5¢-TAATACGACTCACTATAGG-3¢ and
5¢-cgcagatctATGATGGCTGCTGCTTTCTC-3¢, engineered with a BglII
site. Amplified product was cloned in place of GFP using BglII and XhoI,
resulting in mlc2p::NTF (UNC256) and cardiac_actin_p::NTF (UNC255).
BirA and BirA::mCherry were cloned downstream of the CMV promoter
into pBluescript-II KS from pBY2982 (UNC215 and UNC330,
respectively). All transgenic constructs were linearized with XbaI for
transgenesis by restriction enzyme mediated integration (REMI) (Mandel et
al., 2010).
In vitro fertilization and transgenesis of Xenopus embryos
Embryos were obtained and cultured as previously described (Mandel et al.,
2010). One nangram of capped NTF and 1 ng of capped BirA-mCherry
mRNA were injected into one-cell stage embryos. One nanogram NTF only
was injected as a negative control for immunoprecipitation and nuclear
isolation expreriments. Injected embryos were cultured in 4% Ficoll in 1×
MBS for 2-3 hours. Embryos were collected at stage 23 for imaging,
western blotting and immunoprecipitation. Transgenic animals were
generated by REMI (Amaya and Kroll, 1999; Kroll and Amaya, 1996;
Mandel et al., 2010) and genotyped from tailclips as previously reported
(Showell and Conlon, 2009). Fertilized eggs with proper cleavage patterns
were sorted 3 hours post-injection, cultured in 0.1× MMR and collected at
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Immunofluorescence and microscopy
Live brightfield and fluorescent images were taken on a Leica dissecting
microscope fitted with a QImaging Retiga 4000RV camera. Transgenic
embryos were fixed in MEMFA [100 mM MOPS (pH 7.4), 2 mM EGTA,
1 mM MgSO4, 3.7% (v/v) formaldehyde] at room temperature for
30 minutes, washed with 1× PBS + 0.1% Tween 20 (PTw) and incubated
with 1 μg/ml DAPI in PTw for 30-40 minutes at room temperature. Embryos
were washed with PTw and imaged immediately on a Zeiss LSM5 Pascal
confocal microscope. For streptavidin staining, embryos were fixed in 4%
paraformaldehyde for 2 hours at room temperature, washed with 1× PBS
and incubated in 30% sucrose in PBS overnight at 4°C. Embryos were
embedded in OCT and frozen on dry ice. They were then cryosectioned (10
μm thickness) and collected on frosted slides. Slides were stored at –80°C
and warmed at 55°C prior to use for immunostaining. Slides were hydrated
in 1× PBS for 10 minutes and incubated in blocking buffer (10% heat-
inactivated calf serum, 1% Triton X-100, 1× PBS) for 1 hour in a humidity
chamber at room temperature. Slides were then incubated with antibody
solution containing 1:100 anti-GFP (Molecular Probes, A6455) and 1:100
streptavidin Alexa Fluor 568 (Invitrogen) in wash buffer (1% heat-
inactivated calf serum, 0.1% Triton X-100, 1× PBS) overnight at 4°C in a
humidity chamber. The next morning they were washed three times in wash
buffer, and incubated with 1:500 Alexa-Fluor-488-conjugated goat anti-
mouse IgG secondary antibodies (Molecular Probes, A11001) in wash buffer
for 2 hours at room temperature in a dark humidity chamber. Slides were
washed three times and mounted with Prolong Gold Antifade reagent with
DAPI (Invitrogen). Sections were analyzed on a Zeiss 700 confocal
microscope with MyZen software.
Purification of nuclei from Xenopus embryos
Nuclei from Xenopus embryos were prepared as previously described (Deal
and Henikoff, 2011) with minor modifications. Briefly, 100 embryos were
washed in 1× PBS three times and then dropped in groups directly into
liquid nitrogen. Frozen embryos were then ground to a powder with a
ceramic mortar and pestle. Powder was collected in a tube and resuspended
in 6 ml nuclear purification buffer [NPB; 10 mM Tris pH 7.4, 40 mM NaCl,
90 mM KCl, 2 mM EDTA, 0.5 mM EGTA, 0.2 mM dithiothreitol (DTT),
0.5 mM (phenylmethanesulfonyl fluoride (PMSF), 0.5 mM spermine,
0.25 mM spermidine, 1× Roche Complete Protease Inhibitor Cocktail].
DTT, PMSF, spermine, spermidine, and protease inhibitors were all added
to NPB immediately prior to use. The powder was thawed in NPB for about
10 minutes on ice and transferred to a polytetrafluoroethylene tissue grinder
(VWR) and homogenized with 40 strokes. Lysate was filtered through a 100
μm cell strainer to remove cell clumps and centrifuged at 1000 g for
10 minutes to collect crude nuclei. Nuclei were resuspended in Optiprep
(Sigma) diluted to 30% with NPB and pelleted from cell debris at 1000 g
for 10 minutes. Nuclei were then washed three times with NPB to remove
Optiprep prior to affinity isolation.
Streptavidin immunoaffinity purification of NTF
To determine the efficiency of BirA biotinylation of the nuclear targeting
factor protein, nuclear preparations were resuspended in 1 ml HEPES
resuspension buffer (20 mM HEPES, 1.2% polyvinylpyrrolidone, pH 7.4,
1× protease inhibitors) and added dropwise to liquid nitrogen. Nuclear
pellets were thawed and incubated in 5 ml lysis buffer (200 mM K-HEPES
pH 7.4, 1.1 M potassium acetate, 20 mM MgCl2, 1% Tween 20, 10 μM
ZnCl2, 10 μM CaCl2, 500 mM NaCl, 1.0% Triton X-100 and 0.5%
deoxycholic acid, 1× protease inhibitors). Nuclei were sheared on ice with
two 15-second pulses of a Polytron (Thermo Fisher Scientific) at setting 22,
with 1 minute recovery between pulses. Lysates were cleared by
centrifugation at 7500 g for 10 minutes. Once cleared, lysates were
incubated with streptavidin-conjugated magnetic beads (Invitrogen, M-270)
for 30 minutes at room temperature, with rotation. Beads were collected on
a magnet and washed seven times with lysis buffer at room temperature.
Protein was eluted with 30 μl 1× SDS sample buffer (10% glycerol, 100 mM
Tris, pH 6.8, 1% SDS, 5% 2-mercaptoethanol, 10 μg/ml Bromophenol Blue)
at 95°C for 10 minutes, split in two and run on two lanes of a 10% SDS-
PAGE gel. Gels were transferred overnight to PVDF membrane and probed
with mouse anti-GFP (JL8, Clontech, 1:10,000) or streptavidin-HRP
(Jackson ImmunoResearch, 1:10,000). HRP donkey anti-mouse secondary
antibodies (Jackson ImmunoResearch) were used for GFP western blots at
1:10,000. Embryos not injected with BirA mRNA were 
used as a negative control for the immunoaffinity purification
immunoprecipitations.
Affinity isolation of INTACT nuclei
Isolation of tagged nuclei was performed as described previously (Deal and
Henikoff, 2011). All steps were performed at 4°C. Briefly, nuclei were
prepared as described above, re-suspended in 1 ml NPB and immediately
incubated with 50 μl, or 500 μg, of streptavidin-conjugated magnetic beads
(Invitrogen, M-270) for 30 minutes, with end-over-end rotation. During
incubation, P1000 tips were pre-loaded with 1 ml NPBb (NPB with 0.5%
BSA) and laid on their side. After 20 minutes, a tip was inserted into a two-
way stopcock and attached to a magnet. The tip was positioned vertically
and the stopcock was opened to drain the NPBb. After the 30 minute
incubation, the nuclei and bead mixture was mixed with 9 ml NPBt (NPB
with 0.1% Triton X-100). This entire mixture was drawn into a 10 ml
serological pipette and inserted into the broad opening of the P1000 tip-
magnet-stopcock assembly preloaded with 1.2 ml of NPBt. The mixture was
drained from the pipette by slowly releasing from stopcock assembly (flow-
through, non-bead-bound nuclei). During this process, bead-bound nuclei
were collected to the side of the P1000 tip by the magnet. These nuclei were
rinsed in 1 ml NPB, diluted to 10 ml with NPBt and purification was
repeated using a new tip-magnet assembly. Bead-bound and flow-through
samples were centrifuged at 1000 g to pellet the nuclei.
Total RNA isolation and cDNA synthesis
Nuclei were collected in 500 μl Trizol (Invitrogen) for total RNA extraction,
and flash frozen in liquid nitrogen. After storage at –80°C, lysates were
thawed at room temperature, homogenized in Trizol using a P1000 tip,
vortexed briefly, and incubated at room temperature for 5 minutes. Lysate
was centrifuged at 22,000 g for 1 minute to precipitate insoluble material.
Supernatant was transferred to a new tube containing 100 μl chloroform.
The solution was vortexed briefly, incubated at room temperature for
3 minutes, and centrifuged at 12,000 g for 15 minutes at 4°C. The aqueous
layer was transferred to a new tube containing 250 μl isopropyl alcohol.
After 10 minutes of incubation at room temperature, RNA was precipitated
by centrifuging at 12,000 g for 10 minutes at 4°C. RNA was washed twice
with 70% ethanol and spun at 8000 g for 5 minutes between washes. The
pellet was air-dried, and resuspended in 25 μl DEPC-treated water. Samples
were treated with 3 U DNaseI for 30 minutes at 37°C and total RNA was
purified using the RNeasy Mini Kit (Qiagen).
Quantitative RT-PCR (qPCR)
cDNA was generated from total RNA with Superscript II (Invitrogen) and
random primers according to the manufacturer’s instructions. qPCR was
performed on a ABI 7900 Fast HT using SYBRgreen mixed with ROX
passive dye (Sigma). To normalize gene expression gapdh and eef1a were
used. Relative expression was determined using the 2–ΔΔCt method (Livak
and Schmittgen, 2001). Primer sequences for qPCR are summarized in
supplementary material Table S1.
Mass spectrometry-based proteome profiling
Streptavidin-bound nuclei from stage 46 mlc2::NTF; CMV::BirA::mCherry
transgenic embryos were lysed in RIPA buffer (50 mM Tris, pH 8.0,
150 mM NaCl, 0.5% deoxycholate, 1% NP-40, 0.1% SDS) and sonicated
using a Bioruptor (Diagenode) on high for 15 minutes (cycling 30 seconds
on and off) at 4°C. The tube was placed on a magnet and the sample was
eluted off the beads. Total protein yield was measured by the BCA assay
(ThermoFisher Scientific) and equal protein aliquots (~30 μg) from three
stage 46 biological replicates were analyzed by GeLC-MS/MS analysis as
previously described (Guise et al., 2012; Joshi et al., 2013). Briefly, proteins
were resolved on 4-12% Bis-Tris polyacrylamide gels. Replicate lanes were
excised, cut into 1 mm slices, and grouped into ten fractions per lane.
Proteins were digested in parallel with trypsin (12.5 ng/μl in 20 μl of 50 mM
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formic acid/50% ACN. Peptide mixtures were desalted and half (4 μl) of
each sample was analyzed by nanoliquid chromatography-tandem mass
spectrometry using a Dionex Ultimate 3000 nanoRSLC system coupled
online to an LTQ Orbitrap Velos mass spectrometer (ThermoFisher
Scientific). Peptides were separated by reverse phase nLC (Acclaim PepMap
RSLC C18, 1.8 μm, 75 μm × 25 cm) and selected for MS analysis using a
data-dependent ‘Top 15’ acquisition method, as previously described (Greco
et al., 2012; Guise et al., 2012). MS/MS spectra were extracted, filtered, and
searched using Proteome Discoverer/SEQUEST software (v1.4
ThermoFisher Scientific) against a protein sequence database compiled from
UniProt (Swiss-Prot/TrEMBL, 2013-08) containing X. tropicalis and X.
laevis sequences appended with common contaminants (39,623 entries).
Sequences were automatically reversed and concatenated to the forward
sequences to facilitate calculation of peptide and protein false discovery rate
(FDR) estimates. SEQUEST peptide-spectrum matches were analyzed using
Scaffold (v4.0.5; Proteome Software) and the X!Tandem (Beavis
Informatics) refinement search strategy. Probabilities for peptide-spectrum
matches were calculated using Scaffold’s Bayesian-based local FDR scoring
model. Peptides were assembled into protein groups, i.e. database entries
that could not be distinguished by sequence alone. Protein groups were
assembled into clusters to maximize sequence coverage while reducing
database-dependent redundancy. Weighted peptide probabilities and
weighted spectra counts were calculated based on the proportion of unique
and shared spectra among related protein clusters. Weighted spectral counts
for each protein cluster across replicates were then normalized based on the
averaged sum of total weighted spectra between replicates. Data were
exported to Excel for processing. Protein ‘clusters’ that did not possess at
least two exclusive peptides (weight=1.0) in at least one biological replicate
were removed. The coefficient of variation was calculated using weighted
spectral counts (at least three in all replicates).
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